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Little research exists on gender differences regarding prevalence or perceptions of
risk associated with college students’ misuse, illegal consumption, and diversion of
prescription stimulant medications. Data from Mississippi State University
undergraduates (N = 1,714) were examined for gender differences in illicit behaviors and
related risk perceptions. Men were more likely to report consumption and diversion, but
not more likely to report misuse of their own prescription stimulants. Overall, men
reported lower risk perceptions associated with consumption of others’ prescription
stimulants. This finding held true for legal and health risk perceptions for those
uninvolved in diversion or consumption, for health risk perceptions for those who report
consumption, and for social risk perceptions for those who report diversion. Although
some analyses were underpowered, results help clarify how researchers define and
measure these behaviors, determine possible relationships between risk perceptions and
illicit use of prescription stimulant medications, and identify potential targets for
intervention.
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INTRODUCTION
Overview of Attention-Deficit/Hyperactivity Disorder
According to the fifth edition of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-5), Attention-deficit/hyperactivity disorder (ADHD) is a
neurodevelopmental disorder with combinations of symptoms, including inattention,
hyperactivity, and impulsivity (American Psychiatric Association, 2013). Impulsivity
symptoms can be present when one lacks the ability to delay gratification, and can often
have serious consequences in multiple facets of one’s life, such as relationships and
academics (APA, 2013). ADHD occurs in roughly 2.5% of adults and is more frequently
diagnosed in males. Males are also more likely to present with hyperactive and impulsive
features (APA, 2013). ADHD is frequently comorbid with Oppositional Defiant Disorder
in children and often comorbid with Conduct Disorder in older children. These
comorbidities can result in impulsive and aggressive outbursts (APA, 2013).
ADHD in College Populations
The prevalence rate for college students with ADHD is difficult to accurately
determine, in part because rates are often established based on the number of students
registering for special academic services through their university (Weyandt & DuPaul,
2008). Prevalence rates obtained this way may be lower than the actual rate given that not
all college students with ADHD are likely to seek accommodations or other special
1

services. Prevalence rates have also been assessed in college participants using
questionnaires and surveys. However, those rates have ranged from less than five percent
to almost twenty percent, depending on the self-report measures used and cut-off for
criteria (Weyandt & DuPaul, 2008).
College students with ADHD often have trouble adjusting to college life, both
academically and socially. Students with ADHD may struggle academically due to poor
organizational skills or cognitive deficits. In addition, they may struggle to adjust to a
new social circle, due to low self-esteem or other factors (Weyandt & DuPaul, 2008).
ADHD Medications and Negative Outcomes
Stimulant medications for ADHD are used to increase alertness, concentration,
and energy (National Institute on Drug Abuse [NIDA], 2011a). Prescriptions for
stimulant medications have increased dramatically since the early 1990’s, particularly in
the United States, resulting in increased availability (Kaye & Darke, 2012). According to
a research report by NIDA (2011b), the number of prescription stimulants dispensed by
pharmacies increased ten-fold from 1991 to 2010.
There are a variety of negative health, legal, and academic/social outcomes
associated with ADHD stimulant medication use and misuse. Two of the most common
stimulant medications used for ADHD are Dextroamphetamine (Adderall) and
methylphenidate (Ritalin or Concerta). Side effects documented from prescription based
usage of these medications include problems with sleep and decreased appetite, and, in
rare cases, cardiovascular problems (National Institute of Mental Health, 2012). NIDA
(2011a) reported that side effects can also include panic, hallucinations, irritability,
seizure, and stroke, depending on how the medications are ingested. Nonprescription use
2

of stimulant medications is likely to include all of these side effects and possibly more,
especially for individuals who self-medicate with larger or more frequent doses than are
typically prescribed. Misuse of stimulant medications can lead to serious health
problems. The number of visits to the emergency room related to nonmedical use of
Central Nervous System (CNS) stimulants, including prescription stimulant medications,
quadrupled from 2005 to 2011. Combining stimulant medications with alcohol is
particularly dangerous, and can lead to increased risk of alcohol poisoning and alcoholrelated injuries (Substance Abuse and Mental Health Services Administration, 2013).
Prescription stimulant medications are classified as Schedule II substances by the
United States Drug Enforcement Agency, meaning that the substance is considered
dangerous with high abuse and dependence potential (DEA, n.d.). According to the
United States Code, “unlawful distribution” of a Schedule II controlled substance is a
felony offense that can result in up to twenty years in prison, a fine of up to five million
dollars, or both (Yeh, 2012). Possession of a Schedule II controlled substance is a felony
offense that can result in up to one year in prison, a fine of $1,000, or both (Yeh, 2012).
Student misuse of stimulant medications is also linked to a variety of negative
social and academic outcomes. In the case of college students’ illicit use of prescription
stimulants to help with academic performance, some universities have started to include
this type of illicit use as prohibited by the academic honor code (Gardner, 2011). For
example, Northern Illinois University’s Student Code of Conduct prohibits any student
using “unauthorized assistance” on any assignments, which now includes the illicit use of
prescriptions. Wesleyan University added a similarly worded clause to their Code of
Conduct, stating that students are prohibited from using “improper assistance” (Gardner,
3

2011). Although these regulations do not specifically state that illicit use of prescriptions
falls under this rule, this type of illicit use could result in disciplinary action at many
schools, including suspension or expulsion. In terms of social acceptability, Lord,
Brevard, and Budman (2011) found that undergraduate students’ beliefs about overall
prescription drug misuse were varied, ranging from believing that it was acceptable
(16%), believing that it was sometimes acceptable depending on the circumstances
(40%), and believing that it was never acceptable (44%). Most of the participants (89%)
stated that prescription drug misuse was less socially acceptable than marijuana use but,
again, the study by Lord and colleagues asked about general prescription drug misuse,
not specifically prescription stimulant misuse. In terms of the acceptability of illicit use of
prescription stimulant medications, there is evidence that illicit use is not perceived as
particularly socially unacceptable among college students (Judson & Langdon, 2009).
However, studies looking at the social acceptability of illicit prescription stimulants have
been focused mostly on the lower perceived risks of those who report illicit use, rather
than the perceptions of those who do not report illicit use.
Prescription Stimulant Medication Misuse
Stimulant medications are among the most commonly misused medications in
college populations (Garnier et al., 2010). In a meta-analysis of literature involving
stimulant medication diversion and misuse, Kaye and Darke (2012) found that rates of
misuse are higher among college-aged respondents compared to the overall population
(around five percent versus around two percent). Prevalence rates of misuse of ADHD
stimulant medications among college students vary greatly, with lower estimates around
two percent and higher estimates closer to 35%, depending on a variety of factors,
4

including how each study defines “misuse” (McCabe, Teter, & Boyd, 2006). Rabiner et
al. (2009b) found that 31% (36/115) of students with prescriptions for ADHD
medications reported some type of medication misuse, including taking medication more
often than prescribed, at a higher dose than prescribed, or taking someone else’s
medication. Arria and colleagues reported a prevalence rate of roughly 33% (15/45) of
college students with prescriptions reporting “misuse,” including misusing their own
prescription or using someone else’s prescription, but the prevalence rate for those only
misusing their own medication was 27% (12/45) (Arria, Caldeira, O’Grady, et al., 2008).
Other studies have found higher prevalence rates, with one study finding that 45%
(19/42) of students with prescriptions for either Adderall or Ritalin reported misusing
their medication, with a clear majority (63%, 12/19) reporting taking larger doses than
prescribed, though these findings may be skewed by the small sample size and
overwhelming majority (91%) of Caucasian participants (Jardin, Looby, & Earleywine,
2011). Recent studies have reported rates of lifetime misuse for college students ranging
from 5% to almost 50%, but many studies do not specifically and separately measure
misuse, consumption, and diversion behaviors of stimulant medication (Kaye & Darke,
2012). Benson, Flory, Humphreys, and Lee (2015) completed a meta-analysis of the
existing literature on prescription stimulant misuse in college student populations and
found an estimated prevalence rate of 17%, though prevalence studies in this area have a
high amount of heterogeneity, with the lowest prevalence rate at 8% and the highest
prevalence rate at 43%. One significant finding in the literature is that past year
prevalence rates of misuse are lower than lifetime prevalence rates. Further, prevalence
rates tend to be higher in samples that have more participants with ADHD. Although
5

these findings makes sense, many studies do not specifically report the time frame of the
question or the exact breakdown of their sample, making the comparison of prevalence
rates across studies difficult and unclear (Benson et al., 2015).
Prescription Stimulant Medication Consumption
Although not all studies specifically separate misuse of one’s own prescription
medication and taking someone else’s medication, some studies have looked intentionally
at those who consume prescription stimulant medications belonging to others. McCabe,
Teter, and Boyd (2006) studied prevalence of stimulant medication diversion and
consumption activity in college undergraduates, defining “illicit use” as consuming
prescription stimulant medication without a prescription. They found that 8% of the
participants reported illicit use, or consumption, of stimulant medications in their lifetime
and 5% reported illicit use in the past year. DuPont, Coleman, Buchner, and Wilford
(2008) found that 5% of the participants in their study reported taking methylphenidate
without a prescription. On the higher end of prevalence estimates for consumption, one
study of undergraduate students found that 34% reported using a stimulant prescription
medication without a prescription (DeSantis, Webb, & Noar, 2008). In this study, the
sample had equal gender representation and 92% of the participants identified as
“White.” It is possible that this prevalence estimate is higher than others because of the
overrepresentation of Caucasian males and the finding that Caucasian males are at higher
risk for consuming prescription stimulant medication (McCabe et al., 2006). Although
prevalence estimates vary, prevalence of consuming prescription stimulant medication
increased significantly from 2003 to 2013, showing a steady and gradual increase rather
than a large increase during any specific year, suggesting that no one historical event or
6

sudden change in college student environments is responsible for the increase (McCabe,
West, Teter, & Boyd, 2014).
Risk Factors for Misuse and Consumption
There are many characteristics and behaviors that have been found to be risk
factors for misusing stimulant medications. Among students with prescriptions for
ADHD stimulant medication, those who reported licit or illicit drug use were more likely
to misuse their own prescription, including taking larger or more frequent doses, and
more likely to divert (Jardin et al., 2011). In addition, those who misuse their own
medication and those who consume others’ medications have higher rates of using other
substances (Hartung et al., 2013). Caucasian upperclassmen males in Greek organizations
with low grade point averages seem to be most at risk to use prescription stimulant
medications without a prescription (McCabe et al., 2006). Disinhibition and symptoms of
conduct problems affect the relationship between ADHD symptoms and misuse of
prescription stimulants (Van Eck, Markle, & Flory, 2012). Having greater knowledge
regarding prescription stimulant medications, particularly from exposure to
advertisements, and having more positive attitudes about prescription stimulant
medications are both significantly associated with consumption (Bavarian, Flay,
Ketcham, & Smit, 2013).
Motivations for Misuse and Consumption
Many studies have looked at possible motivations for misusing stimulant
prescriptions. In a study of high school seniors, aged 18, McCabe and Cranford (2012)
surveyed a total of 782 stimulant medication misusers to determine common motivations
7

for misusing. This group endorsed a variety of motivations for misusing stimulant
prescription medication: to get more energy (57%), to experiment (55%), to stay awake
(48%), to get high (47%), and to help them lose weight (36%). Over 75% of high school
students misusing stimulant medications in that study reported multiple motives for their
use. However, motivations appear more functional for college students. For those with
prescriptions, the most common motivations for college students to misuse stimulant
medication were to increase concentration during studying and to be able to study longer
(Rabiner et al., 2009b). In another study of misuse among college students, participants
were broken down into four groups: (1) nonusers, or those who had never used
prescription stimulant medications; (2) appropriate users, or those who had prescriptions
and used them as prescribed; (3) medical misusers, or those who misused their own
prescription by taking higher or more frequent doses than prescribed; and (4) nonmedical
misusers, or those who used prescription stimulant medications without a prescription.
They found that getting high as a motivation for misusing was endorsed less (roughly
13% of nonmedical misusers and 24% of medical misusers) than improving academics
(81% of nonmedical misusers and 84% of medical misusers) and studying (54% of
nonmedical misusers and 96% of medical misusers) as motivations (Hartung et al., 2013).
Consumers of others’ prescription stimulant medication may have differing
motives from those who misuse their own prescription. In a study looking at motivations
for misuse and consumption, 56% of consumers reported their use was to help
concentration while studying and 17% reported it was to study longer. In contrast, only
34% of misusers reported helping concentration as their main motivation (Gallucci,
Usdan, Martin, & Bolland, 2014). Further, 32% of misusers reported misusing to help
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concentration in class, whereas only 8% of consumers reported concentration in class as
their main motivation (Gallucci et al., 2014). Although these motivations are slightly
different, the majority of students were reporting primary motivations related to
academics or concentration, with non-academic motivations (e.g., losing weight, feeling
better, and getting high) being reported by less than 5% of both misusers and consumers
(Gallucci et al., 2014). Consumers of prescription stimulant medication report consuming
more frequently (around three or more times) than consumers of sedatives, opioids, and
sleeping medications, who reported consuming one or two times (McCabe et al., 2014).
There is no clear consensus in the literature about the benefits of using stimulant
medications in a controlled manner by individuals without ADHD. Barch and Carter
(2005) found that administration of D-amphetamine decreased reaction times on working
memory tasks in healthy individuals. Mehta et al. (2000) found that subjects given
methylphenidate (or Ritalin) made fewer mistakes on a spatial working memory task.
Breitenstein et al. (2004) gave healthy males doses of Amphetamine and the males were
able to learn novel words faster; learning was still better than the placebo group after one
month. Zeeuws and Soetens (2007) found that D-amphetamine positively impacted
delayed recall at one hour and one day, but did not improve immediate recall. Zeeuws,
Deroost, and Soetens (2010) found that short-term memory was not affected by Damphetamine, but delayed recognition was improved for participants given Damphetamine. Although many studies have found benefits of using stimulant medications
without having ADHD, a multitude of studies have also found no effect of stimulant
medications on healthy individuals, and some studies that even show decreases in
performance (Lakhan & Kirchgessner, 2012). In some studies, participants who were
9

administered types of stimulant medications showed no effect on working memory tasks,
sorting tasks, and reversal learning tasks (Elliott et al., 1997; Mattay et al., 1996;
Clatworthy et al., 2009). In some studies, performance on tasks actually decreased with
an administration of a stimulant. Mattay et al. (2000) found a positive effect on the
hardest level of working memory tasks in individuals who had a lower baseline working
memory capacity and a negative effect on working memory tasks in individuals who had
a higher baseline working memory capacity. Elliott et al. (1997) found that
methylphenidate impaired performance on the second stage of the Tower of London task,
a task of planning. Thus, the functional impact of taking stimulant medications by
individuals without ADHD is not clear from the available experimental evidence. Beyond
the controversy regarding the immediate impact of the medications for individuals
without ADHD, it is possible that individuals without ADHD using prescription stimulant
medication may have negative long-term effects. In a study conducted by Rabiner and
colleagues (2009a), roughly five percent of their college student nonmedical user sample
reported their nonmedical stimulant use led to other substance or nonmedical prescription
use, and roughly five percent reported their nonmedical use resulted in either medical or
substance abuse treatment.
Prescription Stimulant Medication Diversion
Although students engage in prescription stimulant misuse by misusing their own
prescription or taking someone else’s prescription, diversion of medication has also been
observed in college populations. Diversion is defined as sharing, selling, or trading
prescription medications with someone for whom the prescription was not meant
(McCabe et al., 2006). Diversion does not necessarily involve consumption, as someone
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could share, trade, or sell medication without taking it themselves. Sharing or a
combination of sharing and selling is reported more often than selling alone (Garnier et
al., 2010). ADHD medications are among the most commonly diverted. Prevalence rates
of diversion activity have varied greatly in the literature. In a study of college students,
62% of students with prescriptions reported diverting ADHD medications, compared to
the overall reported medication diversion rate of 36% (Garnier et al., 2010). Particularly,
Adderall was the medication that was most diverted (Garnier et al., 2010). This finding of
62% of students diverting ADHD medications is among the highest in the literature.
However, Garnier and colleagues discuss that the estimates found in their study may
actually be lower than true diversion rates, as participants may be hesitant to report illegal
behaviors.
There have been studies showing slightly lower to much lower prevalence rates
for diversion of ADHD medications compared to the 62% reported by Garnier and
colleagues (2010). Gallucci, Martin, and Usdan (2015) found that 59% of current
stimulant medication prescription holders reported diverting in their lifetime. Almost all
of the diverters reported either sharing only or sharing and selling in combination, with
only one participant out of 89 reporting only selling (Gallucci et al., 2015). Further, only
32% of current prescription holders reported diverting in the past month (Gallucci et al.,
2015).
Rabiner et al. (2009b) found that 56% of students in their sample with
prescriptions for stimulant medications had been approached to divert their medication,
although only 26% reported actually sharing or selling their prescriptions to other
students. In a study of college students in an introductory psychology course, 8%
11

reported either selling or giving away stimulant medication (Sharp & Rosen, 2007). In
their study, the obtained percentage could be a low value because the study did not
indicate if their sample was restricted to those who had a prescription. This is important
because those with prescriptions are more likely to divert.
Although the prevalence of diversion has been studied, little research has been
conducted on risk factors, motivations, and how diversion occurs. Although students
report having diverted medication currently or in the past, many of those students also
report diversion behavior to be infrequent, happening only a few times (Garnier et al.,
2010; Rabiner et al., 2009b). Lower frequencies of this behavior are more commonly
reported by those who report sharing, rather than selling, their medications (Gallucci et
al., 2015). One common source for obtaining prescription stimulant medication is friends
or peers, as opposed to family members or diverters they do not know (Garnier-Dykstra,
Caldeira, Vincent, O’Grady, & Arria, 2012; McCabe et al., 2006; Rozenbroek &
Rothstein, 2011). One study of prescription-holding college students found that
participants were four times more likely to report diverting if they had previously used
prescription stimulant medication in a nonmedical way, though the study did not specify
if the nonmedical use was taking their own medication or someone else’s (Gallucci et al.,
2015).
For diverters who reported sharing their medication, the most common motivation
reported was to help another student experiencing academic stress, with 75% of diverters
identifying this as their primary motivation (Gallucci et al., 2015). The second most
common motivation reported was because the recipient had run out of his or her own
medication, with 18% of diverters identifying this as their primary motivation. Only two
12

individuals reported recreational motivations (to help someone party longer or to help a
person get high), at roughly 1% for each behavior. For diverters who reported selling
their medication, the most common motivations were to make extra money (46%) and
because they were offered money for the medication (39%). Covering the cost of
medication was also reported as a primary motivation, but much less frequently, at 8%
(Gallucci et al., 2015).
Gender Differences in Risk Taking Behaviors
Although many studies, as noted above, have shown that misuse, consumption,
and diversion of prescription stimulant medications are relatively common in college
populations, few studies have attempted any gender analyses on those specific risk-taking
behaviors. A meta-analysis of literature on gender differences in risk-taking found that,
overall, males were more likely to engage in risk-taking behavior than females (Byrnes,
Miller, & Schafer, 1999). This significant difference was also found in studies asking
participants to self-report their risk-taking behaviors with drinking and drug use (Byrnes
et al., 1999). These findings were particularly significant for college-aged males (defined
as 18 years old to 21 years old in this meta-analysis) (Byrnes et al., 1999). In a study of
perceptions of behaviors, males were more likely to report risky health behaviors like
smoking or reckless driving, and were more likely to increase risk-taking behaviors (such
as smoking or using ineffective methods of contraception) than females (Gibbons &
Gerrard, 1995). The literature shows that risk-taking behaviors and impulsivity are
correlated, particularly with males. This could be that males have a higher tendency for
impulsivity (Stanford, Greve, Boudreaux, Mathias, & Brumbelow, 1996). Researchers
have noted that males are significantly more likely than females to report illicit use of
13

prescription stimulant medications (Hartung et al., 2013; McCabe et al., 2006; Pilkinton
& Cannatella, 2012). Additionally, motivations for misusing prescription stimulants may
be different for males and females. Females report motives of losing weight, appetite
suppression, and affect regulation more frequently than males (McCabe & Cranford,
2012).
Hall, Irwin, Bowman, Frankenberger, and Jewett (2005) found significant gender
differences regarding the illicit use of stimulant medications and predicting factors of
illicit use. They found that men were more likely to have taken stimulant medications for
nonmedical purposes (17% of men vs. 11% of females), were more likely to know
students who could provide stimulants (37% of men vs. 29% of females), and were more
likely to have taken stimulants with alcohol. They also found that women were more
likely to be aware of the symptoms of ADHD and were more likely to feel pressured by
time commitments. Factors that predicted illicit use of stimulant medications were
different for men and women. For men, accessibility of stimulant medication best
predicted use, whereas with women, use was best predicted by whether another student
was offering the medication (Hall et al., 2005). Perceiving illicit use of prescription
stimulant medication to be a common behavior is a risk factor for consumption. Contrary
to their hypotheses, one study found that women reported more normative perceptions
than men did, indicating that women believed illicit use of these medications to be more
common or normal (Kilmer, Geisner, Gasser, & Lindgren, 2015).
Perception of Risk
Literature regarding risk taking typically focuses on an individual’s goals and
values on a topic, and how these two ideas can determine one’s options for action and
14

outcomes. Risk taking can be subjective from person to person, as some may find some
behaviors riskier than others and perceptions can change over time and circumstance.
Overall, risk-taking behavior is strongly influenced by one’s perception of risk (Byrnes et
al., 1999). One category of theories regarding risk-taking suggests that certain individuals
are more likely to be risk-takers, whereas other individuals are more likely to be riskaverse (Byrnes et al., 1999). One way that individuals perceive risk is through social
comparison and interaction. If one views a behavior or someone engaging in a behavior
as more acceptable, particularly in a social context, they are more likely to be willing to
engage in that behavior.
Risk perceptions have been investigated by other researchers. Judson and
Langdon (2009) conducted a study regarding motivations and beliefs of illicit
prescription stimulant users. The study was conducted with 333 participants at two small
colleges. The most common motivations were increasing concentration (29%) and
staying awake and focused (23%). However, they found that illicit users were less likely
to be concerned about the health risks of misusing stimulant medications, although illicit
users without prescriptions had more knowledge about side effects of stimulant
medications than non-illicit users (Judson & Langdon, 2009).
Social perceptions regarding beliefs about the frequency and ethicality or
acceptability of nonprescription stimulant medication use have also been investigated.
For example, illicit users in the Judson and Langdon (2009) study were more likely to see
illicit use as socially acceptable among their peers. For participants without prescriptions,
their belief about the ethicality of illicit use was a significant predictor of whether they
reported illicit use. In addition, Kilmer et al. (2015) found that college students
15

overestimate others’ illicit use of prescription stimulant medication, and that
overestimation of use is a risk factor for consumption. McCabe (2008) found similar
results, with 70% of participants overestimating the prevalence of consumption of
prescription stimulant medication, and past-year consumers being significantly more
likely to overestimate prevalence. When determining other factors related to how
students perceive others’ prescription stimulant medication illicit consumption, a study of
undergraduate students found that older students with greater history of substance use
were less likely to report negative views of illicit consumption (Lookatch, Moore, &
Katz, 2014). Further, students had lower negative perceptions of consumption of
prescription stimulant medication when used as a study aid, as compared to using the
medication to get high or lose weight (Lookatch et al., 2014).
Some research has begun to target perceptions of health risks associated with
stimulant medications. For example, Arria, Caldeira, Vincent, O’Grady, and Wish (2008)
conducted a study regarding college students’ perception of the harmfulness of
nonmedical use of prescription stimulant medications. The majority of their sample
(67%) reported perceiving the harmfulness of nonmedical use as higher than a slight risk,
and though more females reported high perceived harmfulness (out of the participants
who had the opportunity to nonmedically use prescription stimulants, 59% of females and
51% of males reported high perceived harmfulness), there was not a significant gender
difference in mean ratings of perceived harmfulness (p = 0.16). However, 26% of their
sample reported low perceived harmfulness (endorsing low to slight risk) of using
prescription stimulants nonmedically and members of this group were more than ten
times as likely to report nonmedical use (Arria, Caldeira, Vincent, et al., 2008). Another
16

study of college students found that nonusers were significantly more likely to report
consuming prescription stimulant medications as damaging to mental and physical health
and addictive, suggesting that higher risk perception may be a protective factor against
use (Brandt, Taverna, & Hallock, 2014). In a similar study regarding nonmedical
prescription stimulant use among college students, Weyandt and colleagues found that
roughly 20% of their sample felt that occasional use of stimulant medications was
harmless (Weyandt et al., 2009). Despite nonmedical users having lower perceptions of
harmfulness, negative consequences of nonmedical use are commonly reported, including
health complications, legal consequences, and academic consequences, as described
previously.
The Current Study
Although previous studies have examined basic gender differences in illicit use
and other studies have identified differences in individual domains of risk perception,
these differences have not been examined comprehensively and simultaneously. This
study examined gender differences in misuse, consumption, and diversion of prescription
stimulant medications, and in perceptions of legal, health, and social risks related to
consumption.
Hypotheses:
1. Gender differences in misuse: men with prescriptions for stimulant medication
will be more likely to report misuse of their prescriptions (i.e., either taking
more than prescribed or taking it more frequently than prescribed) than
women with stimulant medication prescriptions.
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2. Gender differences in consumption and diversion activity: men will be more
likely to report engaging in
a.

illegal consumption of prescription stimulant medication (i.e.,
consuming someone else’s prescribed stimulant medication), and

b. illegal diversion (i.e., sharing or selling of prescription stimulant
medication).
3. Gender differences in perception of risk: men will have lower perceptions of
the legal, health, and social risks associated with the consumption of illegally
acquired prescription stimulant medication.
a. Men who are uninvolved with the illegal consumption or diversion of
stimulant medication will rate the legal, health, and social risks as
significantly lower than women who are similarly uninvolved.
b. Men who report illegal consumption of stimulant medication will rate
the legal, health, and social risks as significantly lower than women
who report illegal consumption.
c. Men who report illegal diversion of stimulant medication will rate the
legal, health, and social risks as significantly lower than women who
report illegal diversion.
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METHOD
Participants
Participants were recruited through the Psychology Research Pool (PRP) at
Mississippi State University. The PRP consists of students who complete research to gain
required participation points or extra credit for undergraduate Psychology classes.
Initial data collection occurred during fall of 2013, with subsequent data
collection occurring in spring of 2015. The initial combined sample consisted of 1,869
participants. Although an age minimum was the only exclusionary criteria initially, some
data were discarded. Fourteen questionnaires were discarded because the participants did
not give consent, and thus, did not receive any of the questions. Twenty-four incomplete
questionnaires (defined as answering fewer than 10 questions) were discarded. Three
questionnaires were discarded because the participants’ reported ages were below 18
years old, and 25 questionnaires were discarded because the participants’ reported ages
were above 25 years old. The questionnaire contained validity items to check for
attention and truthfulness. These included items asking participants to report if they had
been truthful, select “agree” from five choices, to identify the color of an orange from
four choices, and to slide a bar to the midpoint of a scale. Twenty-three questionnaires
were discarded because the participants reported that they had not answered truthfully.
Sixty-two questionnaires were excluded due to the participants missing at least two of the
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three validity questions listed above or missing one validity question and skipping at least
one other validity question. Finally, four questionnaires were excluded due to the
participants skipping the question about gender. Data analyses were completed on the
remaining 1,714 participants.
Materials
Participants completed the on-line questionnaire (Kinman, 2014) with up to 159
questions delivered using the Qualtrics platform (Qualtrics, 2015). The questions each
participant received depended on branching logic within the questionnaire. For example,
participants who reported having a prescription for ADHD stimulant medications were
directed to certain follow-up questions. However, most questions were answered by all of
the participants, regardless of prescription status, diversion involvement, or diagnosis.
The questions asked about the following information: ADHD diagnosis and medications,
illicit behaviors related to prescription stimulant medication, beliefs about risk and
protective factors, and basic demographic information. No reliability data for these (or
similar) measures from other studies are available.
To measure the construct of consumption, participants were asked if they had ever
taken stimulant medication without a prescription. The wording of this question is similar
to questions used in other studies in the literature, particularly studies using the Student
Life Survey, though many studies use the term “nonmedical use” or “illicit use” to
discuss this construct (Benotsch, Koester, Luckman, Martin, & Cejka, 2011; Kinman,
2014; McCabe & Boyd, 2005; McCabe & Teter, 2007; Teter, McCabe, LaGrange,
Cranford, & Boyd, 2006).
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To measure the construct of diversion, participants were asked to report the last
time they had shared or sold any of their stimulant medication with someone else. If
participants reported doing either behavior in the past month, past year, or more than a
year ago (e.g., any response other than “never”), they were classified as diverters. The
wording of this question is consistent with the literature, with studies involving diversion
asking about sharing or selling over the participant’s lifetime or during particular time
frames (Gallucci et al., 2015; Garnier et al., 2010; Rabiner et al., 2009b).
To measure the construct of misuse, participants who reported having current
prescriptions for stimulant medication were asked to report if they had ever taken a larger
or more frequent dose in their life. The wording of this question is consistent with other
studies in the literature, though some studies combine taking a larger or more frequent
dose into one question, ask about use that is generally inconsistent with doctor’s orders,
or combine misuse and consumption into one term (Gallucci et al., 2015; Garnier et al.,
2010; Rabiner et al., 2009b).
To determine different types of risk perception of consumption, participants were
asked how much of a legal, health, or social risk is posed by using stimulant medication
without a prescription. Participants responded to a 4-point scale with responses ranging
from “very dangerous” to “not dangerous at all.” The wording of these questions is
consistent with the few studies that have measured perceptions of risk or harm (Arria,
Caldeira, Vincent, et al., 2008; Judson & Langdon, 2009; Weyandt et al., 2009). For
example, Arria, Caldeira, Vincent, et al. (2008) used the word “harmfulness” in their
study instead of “dangerous,” and dichotomized responses into either low or high
perceived harmfulness. Judson and Langdon (2009) asked participants to rate on a seven21

point Likert scale their perceptions of negative health consequences and the ethicality of
illicit use. Weyandt et al. (2009) asked participants to rate on a five-point Likert scale
how much they thought illicit use was “harmless.”
In the demographics portion of the archival questionnaire, the question asking
about gender was not phrased accurately. The question was phrased “Please select your
gender,” although the options given, “Male” or “Female,” were actually identifying sex,
rather than gender. For the full questionnaire, please see Appendix A.
Procedure
Participants located the study on the undergraduate Psychology Research Program
website and filled out the questionnaire delivered via Qualtrics software after completing
an informed consent procedure. The median time taken to complete the questionnaire was
19 minutes, and participants received research credit for completing the survey.
Design
The study used a survey design with analyses featuring between-group
comparisons to address the study’s hypotheses. For the analyses, misuse was defined as
taking a larger or more frequent dose of one’s own prescribed stimulant medication;
consumption was defined as consuming prescription stimulant medication without a
prescription; diversion was defined as sharing or selling prescription stimulant
medication; and involvement was defined as either reporting consumption, diversion, or
both.
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RESULTS
This section includes a review of relevant sample characteristics and descriptions
of each analyses presented in the hypotheses. First, analyses assessed differences in
misuse, consumption, and diversion behaviors between men and women. The final set of
comparisons examined gender differences in perceptions of legal, health, and social risks
of consuming prescription stimulant medications, broken down by type of user (overall
sample, uninvolved, consumer, diverter). Statistical analyses were completed using IBM
SPSS Version 22.0 (IBM, 2013). Power analysis results are presented for each analysis
within the hypotheses. Power analyses were conducted with IBM SPSS SamplePower
3.0.1 (IBM, 2012) on each of the following hypothesis analysis procedures assuming a
two-tailed test with alpha level of .05 with a 95% confidence interval. Power analyses for
Hypothesis 1 and Hypothesis 2 were computed for chi-square analyses. Given that the
software program does not allow for unequal n’s in the ANOVA power calculations,
power analyses for Hypothesis 3 were computed using the t-test for independent samples
analysis procedure.
Demographics and Descriptive Statistics
The final analyzed sample consisted of 1,714 participants. The sample consisted
of 592 men (34.5%) and 1,122 women (65.5%). The majority of the sample (1,236/1,714)
identified as Caucasian (72.1%), with 20.6% (353/1,714) identifying as African
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American, 2.9% (49/1,714) as Other, 2.2% (37/1,714) as Asian, 2.0% (34/1,714) as
Hispanic, and 0.2% (3/1,714) as Pacific Islander. Two participants (0.1%) did not provide
a response to race/ethnicity. The mean age was 19.12, with a standard deviation of 1.32.
The breakdown of class standing was as follows: 38.4% (658/1,714) identified as a first
semester freshman, 19.1% (328/1,714) identified as a freshman (other than first
semester), 20.3% (348/1,714) identified as a sophomore, 13.5% (231/1,714) identified as
a junior, 8.5% (146/1,714) identified as a senior, and 0.2% (3/1,714) identified as
unclassified or as a graduate student.
When asked if they currently held a prescription medication for ADHD, 7.5%
(129/1,713) reported having a current prescription for stimulant medication. Less than
one percent (7/1,713) reported either not knowing the name of their prescription or
having a non-stimulant prescription medication, and thus were not included in current
prescription stimulant medication analyses. Of the 129 participants with current
prescriptions for stimulant medication, 49.6% (64/129) reported misusing their own
medication by either taking a larger or more frequent dose. Of the prescription-holding
participants, 38.8% (50/129) reported taking a larger dose than prescribed, and 35.7%
(46/129) reported taking more frequent doses than prescribed. Roughly twenty-four
percent (413/1,714) of participants reported involvement in illicit use by either
consuming stimulant medication without a prescription, diverting stimulant medication,
or both, with 21.3% of participants (365/1,714) reporting consuming and 7.5%
(128/1,714) reporting diverting medication.
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Hypothesis 1: Gender Differences in Misuse
A chi-square test of independence was performed to examine the relationship
between gender and misuse of prescription stimulant medication. The relationship
between these variables was not significant, χ2 (1) = 0.19, p = 0.66. The comparison
showed that 52.50% (21/40) of prescription-holding men reported taking a larger or more
frequent dose than prescribed, compared to 48.31% (43/89) of prescription-holding
women. Men were not significantly more likely to report misuse of their own medication
than women. However, power analysis results showed a power of 7.0% to yield a
statistically significant result, indicating that this analysis was underpowered. This result
is not surprising, given the smaller sample size of prescription-holding participants and
the small measured difference.
Follow-up analyses were run to determine if there was a gender difference in
specific misuse behaviors. There was not a significant association between gender and
whether participants reported taking a larger dose than prescribed, χ2 (1) = .95, p = .33.
The comparison showed that 45.0% (18/40) of prescription-holding men reported taking
a larger dose than prescribed, compared to 36.0% (32/89) of prescription-holding women.
There was also not a significant association between gender and whether participants
reported taking more frequent doses than prescribed, χ2 (1) = .48, p = .49. The
comparison showed that 40.0% (16/40) of prescription-holding men reported taking more
frequent doses than prescribed, compared to 33.7% (30/89) of prescription-holding
women. Again, these follow-up analyses were using the same prescription-holding
sample as the initial analysis, and thus, were underpowered as well.
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Hypothesis 2: Gender Differences in Consumption and Diversion
There was a significant association between gender and whether participants
reported being a consumer of someone else’s stimulant medication, χ2 (1) = 12.89, p <
.001. The comparison showed that 26.18% (155/592) of men reported consuming
someone else’s prescription stimulant medication, compared to 18.72% (210/1,122) of
women. This analysis indicated that men were significantly more likely to report
consumption. This comparison was adequately powered with power reported as 91.1% to
yield a statistically significant result.
There was also a significant association between gender and whether participants
reported diverting stimulant medication, χ2 (1) = 4.35, p = .037. The comparison showed
that 9.29% (55/592) of men reported diverting prescription stimulant medication,
compared to 6.51% (73/1,122) women. This analysis indicated that men were
significantly more likely to report diversion activity. However, power analysis results
showed a power of 30.6% to yield a statistically significant result, indicating that this
analysis was underpowered.
Hypothesis 3: Gender Differences in Perceptions of Risk
Gender Differences in Overall Participants’ Risk Perceptions
A one-way ANOVA was conducted to examine the relationship between gender
and perception of legal risk of consuming stimulant medication without a prescription.
The mean response for perception of legal risk was 2.02 (SD = .85) for men and 1.79 (SD
= .85) for women. The Levene’s test for equality of variances revealed this assumption to
be violated (F(1, 1,712) = 7.72, p = .006), and thus, the adjusted Welch’s F statistic was
used. There was a significant effect of gender on perception of legal risk, F(1, 1,203.05)
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= 28.29, p < .001. Overall, men in the sample reported lower legal risk ratings than
women. This comparison was adequately powered, with power reported as exceeding
99.9% to yield a statistically significant result.
A one-way ANOVA was conducted to examine the relationship between gender
and perception of health risk of consuming stimulant medication without a prescription.
The mean response for perception of health risk was 2.16 (SD = .92) for men and 1.83
(SD = .87) for women. The Levene’s test for equality of variances was not found to be
violated (F(1, 1,712) = 1.75, p = .186), and thus, the normal ANOVA F statistic was
used. There was a significant effect of gender on perception of health risk, F(1, 1,712) =
52.36, p < .001. Overall, men reported lower health risk ratings than women. This
comparison was adequately powered, with power reported as exceeding 99.9% to yield a
statistically significant result.
A one-way ANOVA was conducted to examine the relationship between gender
and perception of social risk of consuming stimulant medication without a prescription.
The mean response for perception of social risk was 3.00 (SD = .96) for men and 2.88
(SD = 1.00) for women. The Levene’s test for equality of variances revealed this
assumption to be violated (F(1, 1,710) = 7.05, p = .008), and thus, the adjusted Welch’s F
statistic was used. There was a significant effect of gender on perception of social risk,
F(1, 1,247.92) = 6.21, p = .013. Overall, men reported lower social risk ratings than
women. However, power analysis results showed a power of 66.8% to yield a statistically
significant result, indicating that this analysis was underpowered.
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Gender Differences in Uninvolved Participants’ Risk Perceptions
A one-way ANOVA was conducted to examine the relationship between gender
and legal risk as perceived by those uninvolved in consumption or diversion activity. The
mean response for perception of legal risk was 2.01 (SD = .84) for men and 1.72 (SD =
.81) for women. The Levene’s test for equality of variances revealed this assumption to
be violated (F(1, 1,299) = 6.62, p = .010), and thus, the adjusted Welch’s F statistic was
used. There was a significant effect of gender on perception of legal risk, F(1, 790.26) =
33.74, p < .001, indicating that men uninvolved with consumption or diversion had
significantly lower legal risk perceptions than women uninvolved with consumption or
diversion. This comparison was adequately powered with power reported as exceeding
99.9% to yield a statistically significant result.
A one-way ANOVA was conducted to examine the relationship between gender
and health risk as perceived by those uninvolved in consumption or diversion activity.
The mean response for perception of health risk was 2.04 (SD = .91) for men and 1.72
(SD = .83) for women. The Levene’s test for equality of variances was not violated,
indicating that the assumption of homogeneity of variance was met. There was a
significant effect of gender on perception of health risk, F(1, 1,299) = 38.10, p < .001,
indicating that men uninvolved with consumption or diversion had significantly lower
health risk perceptions than women uninvolved with consumption or diversion. This
comparison was adequately powered with power reported as exceeding 99.9% to yield a
statistically significant result.
A one-way ANOVA was conducted to examine the relationship between gender
and social risk as perceived by those uninvolved in consumption or diversion activity.
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The mean response for perception of social risk was 2.88 (SD = 1.00) for men and 2.81
(SD = 1.01) for women. The Levene’s test for equality of variances was not violated,
indicating that the assumption of homogeneity of variance was met. There was not a
significant effect of gender on perception of social risk, F(1, 1,297) = 1.37, p = .242,
indicating that men uninvolved with consumption or diversion did not have significantly
lower social risk perceptions. However, power analysis results showed a power of 21.6%
to yield a statistically significant result, indicating that this analysis was likely
underpowered to find a statistically significant difference.
Gender Differences in Consumers’ Risk Perceptions
For the three following analyses, the Levene’s test for equality of variances was
not violated, indicating that the assumption of homogeneity of variance was met. Power
analysis results indicate that analyses conducted on stimulant medication consumers were
underpowered, with specific power reported with each following analysis. A one-way
ANOVA was conducted to examine the relationship between gender and legal risk as
perceived by consumers of prescription stimulant medications. The mean response for
perception of legal risk was 2.06 (SD = .85) for men and 2.06 (SD = .95) for women.
There was not a significant effect of gender on perception of legal risk, F(1, 363) = .01, p
= .939, indicating that men who illicitly consume did not have significantly lower legal
risk perceptions than women who illicitly consume. For this analysis, power analysis
results showed a power of 5.0% to yield a statistically significant result, indicating that
this analysis was likely severely underpowered to find a statistically significant
difference.
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A one-way ANOVA was conducted to examine the relationship between gender
and health risk as perceived by consumers of prescription stimulant medications. The
mean response for perception of health risk was 2.46 (SD = .91) for men and 2.25 (SD =
.89) for women. There was a significant effect of gender on perception of health risk,
F(1, 363) = 4.69, p = .031, indicating that men who illicitly consume had significantly
lower health risk perceptions than women who illicitly consume. For this analysis, power
analysis results showed a power of 59.7% to yield a statistically significant result,
indicating that this analysis was likely underpowered to find a statistically significant
difference.
A one-way ANOVA was conducted to examine the relationship between gender
and social risk as perceived by consumers of prescription stimulant medications. The
mean response for perception of social risk was 3.27 (SD = .81) for men and 3.19 (SD =
.88) for women. There was not a significant effect of gender on perception of social risk,
F(1, 363) = .80, p = .372, indicating that men who illicitly consume did not have
significantly lower social risk perceptions than women who illicitly consume. For this
analysis, power analysis results showed a power of 14.4% to yield a statistically
significant result, indicating that this analysis was likely severely underpowered to find a
statistically significant difference.
Gender Differences in Diverters’ Risk Perceptions
For the three following analyses, the Levene’s test for equality of variances was
not violated, indicating that the assumption of homogeneity of variance was met. Power
analysis results indicate that analyses conducted on stimulant medication diverters were
underpowered, with observed power reported with each following analysis.
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A one-way ANOVA was conducted to examine the relationship between gender
and legal risk as perceived by diverters of prescription stimulant medications. The mean
response for perception of legal risk was 1.96 (SD = .90) for men and 1.95 (SD = .83) for
women. There was not a significant effect of gender on perception of legal risk, F(1, 126)
= .01, p = .905, indicating that men who divert did not have significantly lower legal risk
perceptions than women who divert. For this analysis, power analysis results showed a
power of 5.0% to yield a statistically significant result, indicating that this analysis was
likely severely underpowered to find a statistically significant difference.
A one-way ANOVA was conducted to examine the relationship between gender
and health risk as perceived by diverters of prescription stimulant medications. The mean
response for perception of health risk was 2.47 (SD = .94) for men and 2.21 (SD = .87)
for women. There was not a significant effect of gender on perception of health risk, F(1,
126) = 2.78, p = .098, indicating that men who divert did not have significantly lower
health risk perceptions than women who divert. For this analysis, power analysis results
showed a power of 36.3% to yield a statistically significant result, indicating that this
analysis was underpowered to find a statistically significant difference. SamplePower
provides graphs that determine power as a function of sample size for each analysis. For
this specific analysis, the sample size required for a power of approximately 80% would
be around 200 participants per gender, or 400 participants total. Thus, with a larger
sample size of diverters, the analysis would be more adequately powered to detect any
statistically significant difference.
A one-way ANOVA was conducted to examine the relationship between gender
and social risk as perceived by diverters of prescription stimulant medications. The mean
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response for perception of social risk was 3.36 (SD = .75) for men and 2.96 (SD = .95)
for women. There was a significant effect of gender on perception of social risk, F(1,
126) = 6.77, p = .010, indicating that men who divert had significantly lower social risk
perceptions than women who divert. For this analysis, power analysis results showed a
power of 72.3% to yield a statistically significant result, indicating that this analysis was
slightly underpowered to find a statistically significant difference.
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DISCUSSION
This study examined three sets of hypotheses related to gender differences in
factors related to the illicit use of prescription stimulant medication in a college
population. The discussion that follows takes into consideration that some of the planned
analyses were underpowered.
Gender Differences in Misuse
First, there was not a significant difference between prescription-holding men and
women in misuse of one’s own prescription stimulant medication. The failure to detect
gender differences in misuse behavior may be due to the fact that this analysis was quite
underpowered, with a 7.0% likelihood of finding a statistically significant difference
given the available data set. This lack of power is most attributable to the small sample
size of prescription holders. However, studies of prescription stimulant medication
misuse are often conducted with smaller samples of prescription holders, with as few as
19 identified misusers (Jardin et al., 2011). Future research studying prescription
stimulant medication misuse should strive to include larger sample sizes to increase
power. In addition to the limited sample size negatively affecting the power of these
analyses, the measured differences between groups also constrained power. As the
differences between means or prevalence rates between men and women increase, the
ability to detect differences also increases.
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Few studies have looked deliberately at gender differences in misuse, as defined
as one who takes one’s own prescription stimulant medication at a larger or more
frequent dose than prescribed. Previous studies have often defined misuse as a
combination of misusing one’s own prescription or consuming someone else’s
prescription (Jardin et al., 2011; Rabiner et al., 2009b). Previous studies have also
analyzed misuse but omitted any analyses with gender (Rabiner et al., 2009b) or analyzed
gender differences in other behaviors but omitted analyzing gender differences in misuse
of one’s own medications (Hall et al., 2005). As previous literature has often combined
the behaviors of misuse and consumption into an overall “illicit use” category, it is
possible that the gender differences found in illicit use in previous literature were
attributable to differences in consumption behavior, rather than misuse of one’s own
prescription stimulant medication. Additionally, any gender differences in prescription
holding status may affect likelihood of misuse, and being a prescription holder may be a
more significant risk factor for misuse than gender.
Gender Differences in Consumption and Diversion
Second, gender differences in consumption and diversion of prescription
stimulants were found in this sample. Specifically, men were more likely to report both
consumption and diversion of prescription stimulant medication. This gender difference
in consumption is consistent with previous literature (Hartung et al., 2013; McCabe et al.,
2006), though some articles detailing gender differences in “illicit use” or “nonmedical
use” report their data based upon a combination of misuse and consumption (Hall et al.,
2005). The literature is less consistent when looking at gender differences in diversion.
Sharp and Rosen (2007) reported that there were no differences in prevalence rates, but
34

did not specify if this included prevalence rates of both consumption and diversion.
McCabe et al. (2006) found no gender differences in undergraduate students in being
approached to divert stimulant medication, though they did not specifically ask if
participants had actually diverted their medication. Garnier et al. (2010) found that men
were more likely to report diverting prescription medications; however, their analyses
combined all kinds of prescription medications, and thus did not specifically look at
gender differences in the diversion of prescription stimulant medications.
Differences observed in this study’s sample may be attributable, at least in part, to
gender differences in overall risk-taking behaviors and health-related risk-taking
behaviors (Byrnes et al., 1999; Gibbons & Gerrard, 1995). Although both analyses were
significant, the analysis of gender differences in reported diversion behavior was
underpowered, with a 30.6% likelihood of finding a statistically significant difference.
An analysis of factors associated with obtained gender differences in diversion behaviors
should await a more adequately powered study.
Gender Differences in Perceptions of Risk
Differences in perceptions of risk may be a beginning of an explanation for why
men report engaging in some behaviors more than women, as men who report lower
legal, health, or social risk perceptions may be more likely to engage in consumption or
diversion. There were gender differences found for different risk perceptions and for
certain subpopulations within the sample. Overall, without separating participants into
groups based on reported illicit use behaviors, men were significantly more likely to
report lower perceptions of legal, health, and social risks of consumption. This is
consistent with findings in the literature of men, particularly in an emerging adult
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population, that men engage in more risk-taking behavior and have lower perceptions of
risk, particularly related to health behaviors (Hall et al., 2005; Arria, Caldeira, O;Grady,
et al., 2008). Recognizing significant legal, health, and social risks associated with the
consumption of prescription stimulant medication should work as a deterrent of such
behavior. Men’s lower risk perception may partially explain why men are more likely to
report illicitly consuming prescription stimulant medication.
When looking solely at participants who reported being uninvolved with
consumption or diversion, men were significantly more likely to report lower perceptions
of legal and health risk. However, for the uninvolved participants, there was not a
significant difference between men and women regarding their perception of social risk,
though the analysis was underpowered. When looking solely at consumers of prescription
stimulant medication, there was only a significant gender difference for perception of
health risk, with men and women not having significantly different perceptions of legal
and social risk, though all three analyses regarding consumers were underpowered. When
looking solely at diverters, there was only a significant gender difference for perception
of social risk, with men and women not having significantly different perceptions of legal
and health risk, though all three analyses regarding diverters were underpowered.
Although the literature provides examples of gender differences in illicit or
nonmedical use of prescription stimulant medication, little research has been done on
gender differences in regards to specific behaviors related to illicit or nonmedical use.
This study found gender differences in perceptions of risk overall, as well as for certain
kinds of risk in specific behavioral groups. Perceptions of social risk were rated lowest
for both men and women, across those uninvolved, consumers, and diverters. For
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participants who reported diverting, men reported lower risk perceptions related to social
risks. One possible explanation for this is the circumstances surrounding diversion of
prescription stimulant medication. Men are more likely to report diverting prescription
stimulant medication, and most diverters are more likely to share their medication to
peers, often to help other students in times of academic stress (Gallucci et al., 2015). It is
possible that the motivations for diverting do not lead to negative perceptions of those
consuming the diverted medication, and thus those consuming do not typically suffer
negative social outcomes from their actions. For participants who reported consuming
prescription stimulant medication, most report consuming doses similar to prescribed
doses. Although men reported lower risk perceptions related to health risks, these lower
risk perceptions may be due to their exposure to few health-related consequences of
relatively low dose illicit use. These results may provide crucial information for how risk
perceptions can affect these behaviors. This also raises an empirical question for future
studies of whether nonprescription-holding consumers who use at a higher dose or higher
frequency have especially low risk perceptions, particularly for health risk.
Two possible frameworks to study the relationship between risk perception and
consumption include social learning theory and the Health Belief Model (HBM). Ford
and Ong (2014) conducted a study of behaviors related to consumption and perceptions
of consumption in terms of social learning theory. They found that students who had
friends who consumed prescription stimulant medications were more likely to report
consuming (Ford & Ong, 2014). Further, students who believed that prescription
stimulant medication would help them study were more likely to report consuming,
suggesting that students were more likely to consume if they believed there would be a
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positive outcome (Ford & Ong, 2014). It is possible that an expectation of positive
outcomes can also be reinforced by witnessing or even hearing about positive outcomes
when friends or peers consume prescription stimulant medication (Ford & Ong, 2014).
Research has shown that social norms can affect behavior in certain situations.
Although there has not been any research specifically looking at masculine social norms
in relation to illicit use of prescription stimulant medication, conforming to masculine
norms of risk-taking and winning has been found to be a risk factor for drinking alcohol
to intoxication (Iwamoto, Cheng, Lee, Takamatsu, & Gordon, 2011). Specifically,
conforming to the norm of risk-taking increases the risk of having problems in relation to
alcohol (Iwamoto et al., 2011). It is possible that these norms may also affect illicit use of
prescription stimulant medication, particularly if consuming prescription stimulant
medication has a perceived benefit of academic success, tying into the winning norm.
The HBM can also be used to frame research in the area of nonmedical use of
prescription stimulant medications. The HBM is a theoretical framework that attempts to
explain why people make certain health-related choices and what factors go into that
decision-making (Janz & Becker, 1984). The HBM has four main dimensions: perceived
susceptibility, perceived severity, perceived benefits, and perceived barriers. Perceived
susceptibility is related to an individual’s perception of his or her own vulnerability to the
effects of a choice. For example, in relation to consumption of prescription stimulant
medication, this dimension would relate to one’s perceived vulnerability to possible
negative health side effects or legal consequences (Janz & Becker, 1984). Higher
perceived vulnerability to negative health consequences has been shown to be related to
lower levels of willingness to engage in consumption of prescription stimulant
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medication (Stock, Litt, Arlt, Peterson, & Sommerville, 2013). Perceived susceptibility
focuses more on whether the individual believes the effects or consequences will or will
not happen to them (Janz & Becker, 1984). Perceived severity is more focused on the
severity of the possible consequences. For example, if there are negative health side
effects from consuming stimulant medication, the individual considers how negative
those consequences may be (Janz & Becker, 1984). Perceived benefits and perceived
barriers make up the concept of a cost-benefit analysis being made when one weighs the
benefits (e.g., possible better grade, easier time focusing) and costs or barriers (e.g.,
having to pay for pills, having to find someone willing to divert) of illicit use.
The HBM can be used as a theoretical framework to study these behaviors.
Although the HBM has been used to explain a variety of health behaviors, including
vaccinations and utilization of clinics, it has been discussed as useful for studying
behaviors related to prescription stimulant medication (DeSantis, Noar, & Webb, 2010).
For example, college students who reported having been exposed to advertisements of
prescription stimulant medications were more likely to report consuming prescription
stimulant medications. Further, having more knowledge and more positive attitudes about
prescription stimulant medications were significantly associated with consumption
(Bavarian et al., 2013). Many students report only hearing about positive outcomes in
relation to consumption of prescription stimulant medications, and hear fewer, if any,
negative outcomes from their peers (Cutler, 2014). Increased knowledge of one’s
susceptibility or the severity of effects may change one’s perceptions. In terms of this
study’s findings, it is possible that men having lower risk perceptions and possibly having
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lower perceived susceptibility to health risks may lead to them being more likely to
engage in the behavior.
Strengths and Limitations
One strength of this study is the delineation of specific behaviors associated with
nonprescription stimulant medication use (i.e., misuse, consumption, and diversion).
Many previous studies combined two or more of these behaviors into the same
terminology. Some researchers have advocated for the adoption of an umbrella term of
“misuse of stimulant medication” to describe both misuse and consumption behaviors
(Benson et al., 2015). Although it is suggested that this would clarify the issue of
terminology, this may make it more difficult to learn enough about the specific target
behaviors to inform the development of prevention or treatment programs.
One limitation of this study is the sole use of a convenience college student
sample. Although stimulant medication consumption and diversion behaviors are more
common on college campuses than among adults in non-university settings (Kaye &
Darke, 2012), use of these populations does not allow generalization of results to
emerging adults not in college, adolescents, or adults. Additionally, this sample was
obtained from a large university in the Southeastern region of the United States, and thus,
may have limited generalizability to other sized universities or universities in different
geographical regions.
Another limitation of this study is the brevity of the included questions regarding
perceptions of risks. For this study, participants were only asked about their perceptions
of the risk of consuming prescription stimulant medication, with no questions asking
about perceptions of the risk of diverting prescription stimulant medication or misusing
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one’s own prescription stimulant medication. It is possible that different trends in
perceptions of risk may be present for these other behaviors. Further, there are no
definitive conclusions regarding the relationship between perceptions of risk and these
behaviors. For example, future research could attempt to longitudinally determine if
lower perceptions of risk are preceding risky behaviors or if risky behaviors lead to lower
perceptions of risk.
A third limitation of this study is that participants were asked their gender, but the
questionnaire only provided participants with answer choices that identified sex (i.e.,
male or female), rather than gender. This distinction creates an interpretation issue based
the theoretical bases of sex or gender differences. If looking at sex, one could theorize
that differences could be primarily related to biological differences, whereas, if looking at
gender, one could theorize that differences could be related to sociocultural constructs of
gender identity and expectations. This could be crucial for future research to determine
possible points of intervention, particularly to use certain theories, whether biological or
sociocultural, to inform intervention programs.
Implications and Future Directions
Although there were not gender differences when looking at legal, health, and
social risk perceptions for all groups, there were gender differences present. When
looking at the overall sample, there were gender differences in all three types of risk
perception and, in each case, men reported perceiving lower levels of risk.
One future direction for this kind of research could include developing
intervention programs through colleges to increase education regarding the risks of illicit
use of prescription stimulant medication. Specifically, the results that men reporting
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consumption have lower perceptions of health risks provide an opportunity to target a
specific population for intervention related to the education of health risks. Although
increasing risk perception may not necessarily lead college students to adopt safer
behaviors (considering the high incidence of unprotected sexual intercourse on campuses
despite high knowledge levels regarding sexually transmitted diseases), it is an empirical
question as to whether increasing awareness of risks could be associated with a decrease
in related behaviors for this behavioral area.
While it is likely that gender-based differences in risk perceptions exist, the
analyses related to consumers and diverters of prescription stimulant medication ranged
from somewhat to severely underpowered. Future research in this area would benefit
from access to larger sample sizes of participants reporting these behaviors. Specifically,
one future direction would be to implement a multisite research project to obtain data
from multiple universities using the same terms and measurement. This tactic may
simplify the process of determining unique and shared characteristics between different
university samples, particularly by ensuring identical measurement of the target concepts
and behaviors across samples.
Another future direction could be expanding the amount of detail collected
regarding different types of risks. In this study, participants were simply asked how much
of a legal, health, or social risk is posed by using stimulant medications without a
prescription. Future studies in this field could delve into specific examples of these
different kinds of risk. For example, participants could have varied ideas of what the
different kinds of risk mean. Some participants may consider going to the emergency
room when answering a question about health risk, whereas other participants may
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consider having unwanted but manageable symptoms, such as lack of appetite or
difficulty sleeping. Legal risk could be perceived as getting a warning from a police
officer or being arrested, being convicted of a misdemeanor or felony and then receiving
a prison sentence or fine, losing a current job, or having something on their record that
would prevent them from a career path they were considering. Social risk could be
perceived as having an uncomfortable encounter with a peer, losing a friend, or losing
status or membership in an activity (e.g., sports team, university job, etc.) due to
disapproval of illicit use. A future direction could be to obtain qualitative information
from college students regarding their perceptions of risks, as there may be more
significant gender differences when more detail is ascertained. This can also be framed
by the HBM, to determine college students’ perceptions of their susceptibility and the
severity of side effects or consequences. Qualitative information gathered could also
include college students’ descriptions of any cost-benefit analyses that go into deciding
whether to engage in these illicit behaviors. Although some college students report
consuming prescription stimulant medications without previous planning, college
students also report specifically planning to consume (Kerley, Copes, & Griffin, 2015;
Vrecko, 2015). Future research could attempt to determine how college students who
plan to consume may make that decision.
With the knowledge that illicit use of prescription stimulant medication is a
relatively common occurrence on college campuses and has increased steadily in the past
decade, it is crucial that research begin to tease apart specific information about these
various behaviors. Researchers have begun to move beyond simply studying prevalence
and are now studying potential risk factors and maintaining factors. As researchers better
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understand motivations, perceptions, and the impact of relevant gender differences on
these and related variables, this area of research can gain more specific knowledge about
these behaviors and the factors surrounding and affecting them. Further research should
particularly focus on teasing apart the details of risk perception, and how those
perceptions may affect college students’ behaviors. Specifically, approaching research in
this area through the frameworks of social learning theory or the HBM may be beneficial
to understanding relevant social effects or cost-benefit analyses made by college students.
This trend in research can benefit future intervention programs aimed at decreasing these
behaviors and the negative consequences of illicit use.
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Questionnaire

Q2 Have you ever been diagnosed with ADHD (Attention Deficit Hyperactivity
Disorder)?
 Yes (1)
 No (2)
Q3 Do you CURRENTLY have a prescription for ADHD medication?
 Yes, a stimulant medication like Adderall, Concerta, Ritalin, Focalin, Vyvanse,
Daytrana patch, Dexedrine, Metadate (1)
 Yes, a non-stimulant medication like Catapres, Clonidine, Intuniv, Desipramine,
Norpramin, Strattera, Atomexetine, Tenex, Effexor, Venlafaxine. (2)
 Yes, not sure what it is (3)
 No (4)
Answer If Do you CURRENTLY have a prescription for ADHD medication? Yes Is
Selected
Q4 Have you ever been approached to divert (sell or share) your stimulant medication?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medication? Yes Is
Selected
Q5 Where do you get your prescription for the stimulant medication?
 MSU Student Health Center (1)
 Other (2)
Answer If Do you CURRENTLY have a prescription for ADHD medication? Yes Is
Selected
Q6 Where do you usually get your prescription for the stimulant medication filled?
 MSU's Student Health Center (1)
 Starkville area pharmacy (2)
 Other (3)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q7 Which stimulant medication are you prescribed?
 Concerta (1)
 Vyvanse (2)
 Adderall (3)
 Ritalin (4)
 Other (5) ____________________
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Answer If Do you CURRENTLY have a prescription for ADHD medication? Yes, a
stimulant medication like Adderall, Concerta, Ritalin, Focalin, Vyvanse, Daytrana patch,
Dexedrine, Metadate Is Selected
Q8 When was the last time you shared any of your prescription stimulant medication with
someone else (e.g., Adderall, Vyvanse, Concerta)?
 Past month (1)
 Past year (2)
 More than a year ago (3)
 Never (4)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q9 How helpful is this medication?
______ Slide the bar to indicate how helpful you believe this medication to be. (1)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q10 Have you ever taken a larger dose than prescribed (e.g., 2 pills at one time instead of
1, 3 pills instead of 2) in your life?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q11 Have you taken a larger dose than prescribed (e.g., 2 pills at one time instead of 1, 3
pills instead of 2) in the past month?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q12 Have you taken a larger dose than prescribed (e.g., 2 pills at one time instead of 1, 3
pills instead of 2) in the past year?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q13 Did you ever take a larger dose than prescribed (e.g., 2 pills at one time instead of 1,
3 pills instead of 2) before college?
 Yes (1)
 No (2)
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Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q14 Have you taken the medication more frequently (e.g., 2x/day instead of once, 3x/day
instead of 2x) than prescribed in the past month?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q15 Have you taken the medication more frequently (e.g., 2x/day instead of once, 3x/day
instead of 2x) than prescribed in the past year?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medica... Yes Is
Selected
Q16 Have you taken the medication more frequently (e.g., 2x/day instead of once, 3x/day
instead of 2x) than prescribed in your life?
 Yes (1)
 No (2)
Answer If Do you CURRENTLY have a prescription for ADHD medication? Yes, a
stimulant medication like Adderall, Concerta, Ritalin, Focalin, Vyvanse, Daytrana patch,
Dexedrine, Metadate Is Selected
Q17 If you have a prescription for a stimulant medication, what BEST describes how you
USUALLY take your medication?"
 Never (1)
 Weekdays only (2)
 Weekends only (3)
 Weekdays plus weekends (4)
 I only use it for special events (5)
Q18 Have you PREVIOUSLY had a prescription for a stimulant medication but DON'T
currently?
 Yes (1)
 No (2)
Answer If Have you PREVIOUSLY had a prescription for a stimulant me... Yes Is
Selected
Q19 Were you ever approached to divert (sell or share) your stimulant medication?
 Yes (1)
 No (2)
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Answer If Have you PREVIOUSLY had a prescription for a stimulant me... Yes Is
Selected
Q20 Which stimulant medication were you prescribed?
 Concerta (1)
 Vyvanse (2)
 Adderall (3)
 Ritalin (4)
 Other (5) ____________________
Answer If Have you PREVIOUSLY had a prescription for a stimulant me... Yes Is
Selected
Q21 When was the last time (when you were taking the prescribed stimulant medication)
that you shared any with someone else (e.g., Adderall, Vyvanse, Concerta)?
 High school (10-12th grades) (1)
 Junior high school (7th-9th) (2)
 Elementary school (6th grade or earlier) (3)
 Never (4)
Answer If Have you PREVIOUSLY had a prescription for a stimulant me... Yes Is
Selected
Q22 How helpful was this stimulant medication when you were taking it?
______ Slide the bar to indicate how helpful you believe this medication to be. (1)
Q23 If you have NEVER been diagnosed with ADHD, how likely is it that you have
undiagnosed ADHD problems that might benefit from medication?
______ Slide the bar to best answer the question. (1)
Q24 Have you ever taken stimulant medication (Adderall, Concerta, Vyvanse, etc.)
without a prescription?
 Yes (1)
 No (2)
Q25 Please rate how difficult you think your current major is compared to other majors.
 Very difficult (1)
 Difficult (2)
 Somewhat Difficult (3)
 Neutral (4)
 Somewhat Easy (5)
 Easy (6)
 Very Easy (7)
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Q26 Have any of your immediate family members (i.e., parents/siblings) ever been
diagnosed with ADHD?
 None (1)
 1 family member (2)
 2 family members (3)
 > 2 family members (4)
Q27 How difficult is your current class load this semester?
 Very Difficult (1)
 Difficult (2)
 Somewhat Difficult (3)
 Neutral (4)
 Somewhat Easy (5)
 Easy (6)
 Very Easy (7)
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Q28 The following questions will ask you to rate how useful stimulant medication is for
helping with different tasks. (If you do not or have not taken this medication how well do
you think it would help with these tasks.)
Always useful Often useful Sometimes Rarely useful Never useful
(1)
(2)
useful (3)
(4)
(5)
Studying for
exams (1)











Writing papers
(2)
Taking exams
(3)





















Staying awake
in class (4)











Giving class
presentations
(5)











Getting to class
on time (6)











Earning a
higher GPA (7)































Enhance other
substances (10)











Enhancing
athletic
performance
(11)











Building
muscle (12)











Suppress
appetite (13)
Reduce fatigue
(14)





















Pulling an "all
nighter" to
study or write a
paper (8)
Enhancing
eligibility for
scholarship/
financial
support (9)
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Q42 Other?
Q43 Do you feel the medication helps you (or would help you if you were taking it):
Yes (1)
No (2)
To avoid getting a worse
grade? (1)





To avoid academic
suspension/ probation? (2)
To avoid losing scholarship
money? (3)









To increase concentration? (4)





To increase alertness? (5)





Q48 Other?
Q49 How competitive are you about your grades?
______ Slide bar to best answer the question. (1)
Q50 What do you think is the percentage of college students, whether they have a
prescription or not, that have EVER used a stimulant medication in a non-prescribed
manner (e.g., taking a higher dose, taking more frequently, or combining with other
medications or substances)?
______ Slide bar to best answer the question. (1)
Q51 When stimulant medication is obtained without a prescription, which is more
common - that the medication was sold or shared?
______ Slide bar to best answer the question (1)
Q52 When was the last time someone shared any of their prescription stimulant
medication with you (e.g., Adderall, Vyvanse, Concerta)?
 Past month (1)
 Past year (2)
 More than a year ago (3)
 Never (4)
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Q53 When was the last time you sold any of your prescription stimulant medication to
someone else (e.g., Adderall, Vyvanse, Concerta)?
 Past month (1)
 Past year (2)
 More than a year ago (3)
 Never (4)
Q54 When was the last time someone sold stimulant medication to you (e.g., Adderall,
Vyvanse, Concerta)?
 Past month (1)
 Past year (2)
 More than a year ago (3)
 Never (4)
Q55 Please rank these possible motivations for why YOU would share or sell stimulant
medication. (Multiple selections are allowed, but rank only motivations you think are
relevant, click and drag options.)
Why YOU would share or sell stimulant
Not relevant
medication? (Drag items here & rank)
______ To be liked/ accepted (1)

______ To be liked/ accepted (1)

______ To avoid being disliked/ rejected (2) ______ To avoid being disliked/ rejected (2)
______ Financial gain (3)
______ Financial gain (3)
______ To help someone (4)

______ To help someone (4)

______ Recreational benefits (5)

______ Recreational benefits (5)

Q56 What do you believe are OTHERS’ motivations to sharing or selling medication?
(Multiple selections are allowed, but rank only motivations you think are relevant, click
and drag options)
Why would OTHERS share or sell
Not relevant
medication? (Drag items here & rank)
______ To be liked/ accepted (1)

______ To be liked/ accepted (1)

______ To avoid being disliked/ rejected (2) ______ To avoid being disliked/ rejected (2)
______ Financial gain (3)
______ To help someone (4)

______ Financial gain (3)
______ To help someone (4)

______ Recreational benefits (5)

______ Recreational benefits (5)
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Q57 Would YOU share or sell medication more for financial gain or for social reasons?
 Financial gain (1)
 Social (2)
 Other/ NA (3) ____________________
Q58 Would OTHERS share or sell medication more for financial gain or for social
reasons?
 Financial gain (1)
 Social (2)
 Other/ NA (3) ____________________
Q59 Select agree
 Strongly disagree (1)
 Disagree (2)
 Neither Agree nor Disagree (3)
 Agree (4)
 Strongly Agree (5)
Q60 Have your family members ever shared prescribed medications with family
members or friends who have a similar need but no prescription? (e.g., pain killers, antianxiety agents, ADHD medication)
 Yes (1)
 No (2)
Q61 Have your roommates/floor mates ever shared prescribed medications with others
who have a similar need but no prescription? (e.g., pain killers, anti-anxiety agents,
ADHD medication)
 Yes (1)
 No (2)
Q62 Have YOU ever shared prescribed medications with others who have a similar need
but no prescription? (e.g., pain killers, anti-anxiety agents, ADHD medication)
 Yes (1)
 No (2)
Q63 What desired effects do you think YOU would get from using stimulant medication?
(multiple selections allowed)
 Increased concentration (1)
 Increased alertness (2)
 Help with studying (3)
 Produce a "high" (4)
 None (5)
 Other (6) ____________________

61

Q64 What desired effects do you think OTHERS would get from using stimulant
medication? (multiple selections allowed)
 Increased concentration (1)
 Increased altertness (2)
 Help with studying (3)
 Produce a "high" (4)
 None (5)
 Other (6) ____________________
Q65 How capable is stimulant medication of producing a “high” for the user?
 Very capable (1)
 Moderately capable (2)
 Somewhat Capable (3)
 Incapable (4)
Q66 How capable is stimulant medication in helping increase concentration?
 Very capable (1)
 Moderately capable (2)
 Capable (3)
 Incapable (4)
 Very incapable (5)
Q67 How capable is stimulant medication in helping increase alertness?
 Very capable (1)
 Moderately capable (2)
 Capable (3)
 Incapable (4)
 Very incapable (5)
Q68 How capable is stimulant medication in helping with studying?
 Very capable (1)
 Moderately capable (2)
 Capable (3)
 Incapable (4)
 Very incapable (5)
Q69 How strongly do you believe that someone has ever given you a stimulant
medication without your permission or awareness?
 Strongly believe (1)
 Suspect (2)
 Do not believe (3)
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Q70 Have YOU, whether you’ve had a prescription or not, ever had a side effect from an
ADHD-related medication that required a trip to your doctor (non-emergency)?
 Yes (1)
 No (2)
Q71 Have YOU, whether you’ve had a prescription or not, ever had a side effect from an
ADHD-related medication that required a trip to an emergency room?
 Yes (1)
 No (2)
Q72 Do you know of ANYONE, whether they had a prescription or not, who had a side
effect from using an ADHD-medication that required a trip to an emergency room?
 Yes (1)
 No (2)
Q73 Do you know of ANYONE, whether they had a prescription or not, who had a side
effect from using an ADHD-medication that required a trip to their doctor (nonemergency)?
 yes (1)
 No (2)
Q74 How often do you think people have a side effect from an ADHD-related medication
that requires a trip to a doctor (non-emergency)?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Always (5)
Q75 How often do you think that people ever have a side effect from an ADHD-related
medication that requires a trip to the emergency room?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Always (5)
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Q76 When using ADHD stimulant medication what types of side effects have YOU
experienced?
Never had Rarely (2) Sometimes Often (4) Always (5) Never Used
that effect
(3)
(6)
(1)
Headaches
(1)













Stomach
aches (2)
Irritability
(3)

























Sadness (4)













Reduced
appetite (5)













Sleep
difficulty (6)













Dizziness (7)













Difficulty
getting along
with friends
(e.g.,
irritability,
mood
swings) (8)













Q84 What color is an orange?
 Pink (1)
 Orange (2)
 Blue (3)
 Black (4)
 Red (5)
Q85 Have YOU ever combined stimulant medication with energy drinks?
 Yes, I have combined stimulant medication and energy drinks. (1)
 No, I have only used stimulant medications. (2)
 No, I have only used energy drink. (3)
 No, I have never used either. (4)
Q86 Do you know someone that has combined stimulant medication with energy drinks?
 Yes (1)
 No (2)
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Q87 If you have EVER used stimulant medication in a non-prescribed fashion (i.e.,
higher frequency or higher dose level), when did that typically happen?"
 Never (1)
 Weekdays only (2)
 Weekends only (3)
 Weekdays plus weekends (4)
 Only for special events (5)
Q88 For what events do you take stimulant medication? (check all that apply)
 exams (1)
 papers (2)
 partying (3)
 school/work days (4)
 athletic events (5)
 other (6)
Q89 Have you ever been charged with DUI (driving under the influence)?
 Yes (1)
 No (2)
Q90 If you have a current prescription for ADHD, how difficult was it to get your
prescription renewed the last time you renewed it?
 Not at all (1)
 Some difficulties (2)
 Very easy (3)
 N/A (4)
Q91 If you have a current prescription for ADHD, how difficult was it to get your
prescription filled?
 Not at all (1)
 Some difficulties (2)
 Very easy (3)
 NA (4)
Q92 How much of a LEGAL risk is posed by using stimulant medication with a
prescription?
 Very Dangerous (1)
 Dangerous (2)
 Slightly Dangerous (3)
 Not Dangerous at all (4)
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Q93 How much of a LEGAL risk is posed by using stimulant medication without a
prescription?
 Very Dangerous (1)
 Dangerous (2)
 Slightly Dangerous (3)
 Not Dangerous at all (4)
Q94 How much of a HEALTH risk is posed by using stimulant medication with a
prescription?
 Very Dangerous (1)
 Dangerous (2)
 Slightly Dangerous (3)
 Not Dangerous at all (4)
Q95 How much of a HEALTH risk is posed by using stimulant medication without a
prescription?
 Very Dangerous (1)
 Dangerous (2)
 Slightly Dangerous (3)
 Not Dangerous at all (4)
Q96 How much of a SOCIAL risk (e.g., rejection by or criticism from others) is posed
by using stimulant medication with a prescription?
 Very Dangerous (1)
 Dangerous (2)
 Slightly Dangerous (3)
 Not Dangerous at all (4)
Q97 How much of a SOCIAL risk (e.g., rejection by or criticism from others) is posed
by using stimulant medication without a prescription?
 Very Dangerous (1)
 Dangerous (2)
 Slightly Dangerous (3)
 Not Dangerous at all (4)
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Q98 Rate yourself on each of the following items using the rating system below. Only
rate actual behavior be it verbal and/or physical. Do not include in your ratings thoughts
not followed by any action or fantasies. For these questions it is important to rate any
events that have occurred over your lifetime (including your years as a teenager and a
young adult). How Many Times Would You Say You Did the Following Things Over
the Course of Your Life to Date? "Throw" a temper tantrum (for example: screaming,
slamming doors, throwing things when frustrated to the "breaking point")
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q99 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Get into physical fights with other people
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q100 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Get into verbal fights or arguments with other people
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q101 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Deliberately hit another person (or an animal) in anger
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
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Q102 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Deliberately struck or deliberately broke objects, (for example:
windows, dishes, etc.) in anger
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q103 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Deliberately tried to physically hurt yourself in anger or
desperation
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q104 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Deliberately tried to end your life or kill yourself in anger or
desperation
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q105 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Had discipline problems in school which resulted in a reprimand
by the school principal, or in a suspension, or expulsion from school
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
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Q106 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Had difficulties with bosses or supervisors which resulted in a
physical or verbal fight and led to a reprimand, a demotion, or a firing from your
job
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q107 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date? Had difficulties with other people due to lying, stealing, sexual
promiscuity, involvement in activities that were questionably legal, disregard for the
rights of others
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q108 How Many Times Would You Say You Did the Following Things Over the Course
of Your Life to Date?
Had difficulties with the law or police which resulted in a
warning, arrest, or conviction for a misdemeanor or felony
offense
 0 = never happened (1)
 1 = only happened "once" (e.g., one time) (2)
 2 = happened "a couple" or "a few" (e.g., 2-3) times (3)
 3 = happened "several" (e.g., 4-9) times (4)
 4 = happened "many" (e.g., 10+) times (5)
 5 = happened "so many" times that I couldn't give a number (6)
Q109 Pull slider as close to 50% as you can.
______ Select 50%. (1)
Q110 Have you ever thought about or attempted to kill yourself?
 0= No (2)
 1 (3)
 2 (4)
 3 (5)
 4 (6)
 5 (7)
 6= I have attempted to kill myself
and I think I really hoped to die (8)
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Q111 How often have you thought about killing yourself in the past year?
 0= Never (1)
 1 (2)
 2 (3)
 3 (4)
 4= Very often (5)
Q112 Have you ever told someone that you were going to commit suicide, or that you
might do it?
 0= No (1)
 1 (2)
 2= Yes, during more than one period of time (3)
Q113 How likely is it that you will commit suicide one day?
 0= No chance at all (1)
 1 (2)
 2 (3)
 3 (4)
 4= Very likely (5)
Q114 How safe do you think it would be to take a double dose (e.g., 2 pills vs. 1) than a
typical stimulant prescription calls for?
______ Slide bar to best answer the question. (1)
Q115 If you have ever taken stimulants from a friend who had a prescription, how did the
amount YOU typically used compare to THEIR usual prescription dose?
 Less than their dose (e.g., 1 when 2 is normal) (1)
 Equal to their dose (2)
 Double their dose (e.g., double normal dose or more) (3)
 More than double their dose (4)
 Never taken medication (5)
Q116 How satisfied are you with your body?
 Very Dissatisfied (1)
 Dissatisfied (2)
 Neutral (3)
 Satisfied (4)
 Very Satisfied (5)
Q117 If someone you know reports they have ADHD (attention deficit hyperactivity
disorder) your view of them is likely to:
 Become more positive (1)
 No change (2)
 Become more negative (3)
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Q118 Do you disapprove of people WITH a prescription trying stimulant medications
once or twice?
 Yes (1)
 No (2)
Q119 Do you disapprove of people WITH a prescription trying stimulant medications
regularly?
 Yes (1)
 No (2)
Q120 Do you disapprove of people WITHOUT a prescription trying stimulant
medications once or twice as a study aid?
 Yes (1)
 No (2)
Q121 Do you disapprove of people WITHOUT a prescription trying stimulant
medications regularly as a study aid?
 Yes (1)
 No (2)
Q122 Do you disapprove of people WITHOUT a prescription trying stimulant
medications once or twice for recreational purposes?
 Yes (1)
 No (2)
Q123 Do you disapprove of people WITHOUT a prescription trying stimulant
medications regularly for recreational purposes?
 Yes (1)
 No (2)
Q124 Do you disapprove of people WITHOUT a prescription trying stimulant
medications once or twice for diet/ appetite control purposes?
 Yes (1)
 No (2)
Q125 Do you disapprove of people WITHOUT a prescription trying stimulant
medications regularly for diet/ appetite control purposes?
 Yes (1)
 No (2)
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Q126 How often do you have trouble wrapping up the final details of a project once the
challenging parts have been done?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q127 How often do you have difficulty getting things in order when you have to do a
task that requires organization?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q128 How often do you have problems remembering appointments or obligations?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q129 When you have a task that requires a lot of thought, how often do you avoid or
delay getting started?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q130 How often do you fidget or squirm with your hands or feet when you have to sit
down for a long time?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
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Q131 How often do you feel overly active and compelled to do things, like you were
driven by a motor?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q132 How often do you make careless mistakes when you have to work on a boring or
difficult project?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q133 How often do you have difficulty keeping your attention when you are doing
boring or repetitive work?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q134 How often do you have difficulty concentrating on what people say to you, even
when they are speaking to you directly?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q135 How often do you misplace or have difficulty finding things at home or at work?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
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Q136 How often are you distracted by activity or noise around you?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q137 How often do you leave your seat in meetings or other situations in which you are
expected to remain seated?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q138 How often do you feel restless or fidgety?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q139 How often do you have difficulty unwinding and relaxing when you have time to
yourself?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q140 How often do you find yourself talking too much when you are in social situations?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q141 When you're in conversation, how often do you find yourself finishing the
sentences of the people you are talking to, before they can finish themselves?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
74

Q142 How often do you have difficulty waiting your turn in situations when turn taking
is required?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q143 How often do you interrupt others when they are busy?
 Never (1)
 Rarely (2)
 Sometimes (3)
 Often (4)
 Very often (5)
Q144 How old are you (years)?
Q145 Please select your gender.
 Male (1)
 Female (2)
Q146 Please select your ethnicity.
 Caucasian (1)
 African American (2)
 Asian (3)
 Pacific Islander (4)
 Hispanic (5)
 Other (6)
Q147 What is your current living arrangement?
 Single sex resident hall (1)
 Co-ed hall (2)
 Other university housing (3)
 At home (4)
 Fraternity/ Sorority house (5)
 Off campus (6)
Q148 Please select what class mostly closely matches your current credit hour total.
 Freshman (first semester) (1)
 Freshman (other) (2)
 Sophomore (3)
 Junior (4)
 Senior (5)
 Unclassified or graduate (6)
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Q149 What is your current Greek life affiliation?
 Member (1)
 Non- Member (2)
 Past member (3)
Q150 What is your current GPA (actual, if available; estimated if first semester college
student)?
______ GPA (1)
Q151 What is your current major?
Q152 How many credit hours are you enrolled in this semester?
Q153 Are you or have you ever been a member of the Honors College?
 Yes (1)
 No (2)
Q154 How challenging is your major for you?
______ Slide bar to best answer the question. (1)
Q155 Have you ever combined stimulant medication with alcohol?
 Yes (1)
 No (2)
Q156 Have you ever combined stimulant medication with other drugs?
 Yes (1)
 No (2)
Q157 FATHER'S highest level of education
 Doctoral degree (1)
 Masters degree (2)
 Bachelor degree (3)
 Associates degree (4)
 High school diploma/ GED (5)
 Less than high school diploma (6)
Q158 MOTHER'S highest level of education
 Doctoral degree (1)
 Masters degree (2)
 Bachelor degree (3)
 Associates degree (4)
 High school diploma/ GED (5)
 Less than high school diploma (6)
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Q159 Were you truthful with the responses you provided?
 Yes (1)
 No (2)
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January 21, 2015
Joanna Hachtel
Psychology
Mailstop 9514
RE: HRPP Study #14-410 : Perceptions of Stimulant Use Among College Students II
Dear Ms. Hachtel:
This email serves as official documentation that the above referenced project was
reviewed and approved via expedited review for a period of 1/21/2015 through 1/15/2016
in accordance with 45 CFR 46.110 #7. Please note the expiration date for approval of this
project is 1/15/2016. If additional time is needed to complete the project, you will need to
submit a Continuing Review Request form 30 days prior to the date of expiration. Any
modifications made to this project must be submitted for approval prior to
implementation. Forms for both Continuing Review and Modifications are located on our
website at http://www.orc.msstate.edu/humansubjects/forms/.
Any failure to adhere to the approved protocol could result in suspension or termination
of your project. Please not! e that the HRPP reserves the right, at anytime, to observe you
and any associated researchers as they conduct the project and audit research records
associated with this project.
Please note that the MSU HRPP accreditation for our human subjects protection program
requires an approval stamp for consent forms. The approval stamp will assist in ensuring
the HRPP approved version of the consent form is used in the actual conduct of research.
Your stamped consent form will be attached in a separate email. You must use the
stamped consent form for obtaining consent from participants.
Please refer to your study number (#14-410) when contacting our office regarding this
project.
We wish you the very best of luck in your research and look forward to working with you
again. If you have questions or concerns, please contact Jodi Roberts at
jroberts@orc.msstate.edu or call 662-325-2238.
Sincerely,
Jodi Roberts, Ph.D.
IRB Officer
cc: SONA
Kevin Armstrong (Advisor)
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